Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks

Key Points Long coronary artery lesions are increasingly treated with new technologies including current generation drug eluting stents (DES) despite a lack of robust data on outcomes. In the current study, patients receiving Xience V DES for very long lesions (>35 mm) compared to lesions 25–35 m...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2017-05, Vol.89 (6), p.992-993
Main Authors: Beale, Charles E., Dawn Abbott, J.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Key Points Long coronary artery lesions are increasingly treated with new technologies including current generation drug eluting stents (DES) despite a lack of robust data on outcomes. In the current study, patients receiving Xience V DES for very long lesions (>35 mm) compared to lesions 25–35 mm had similar outcomes. Future research should address late outcomes, stent thrombosis rates, as well as investigation of lesions greater than 60 mm.
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.27073